Chester County News and Community Website
LANGHORNE, PA — The U.S. Food and Drug Administration has extended the review period for Savara Inc.’s (Nasdaq: SVRA) biologics license application for molgramostim by three months, setting a new …
FDA Extends Review of Savara’s Molgramostim Application to November Read More
YARDLEY, PA — Acumetis, a life sciences commercialization company formed by combining five consultancies, launched April 14, 2026, to provide integrated services across the biopharmaceutical product lifecycle, the company announced.
Acumetis Launches as Combined Life Sciences Consulting Firm Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) will present new clinical data on its investigational therapy molgramostim at the ATS International Conference in Orlando, Florida, May 17–20, 2026, the company …
Savara to Present Molgramostim Data at ATS 2026 Conference Read More
WARMINSTER, PA — Havis announced the recent launch of new docking stations designed for Panasonic TOUGHBOOK 55 and 56 laptops, aimed at improving usability and performance for mobile professionals in …
Havis Launches Docking Stations for Panasonic TOUGHBOOK 55, 56 Read More NEWTOWN, PA — Dionis Goat Milk Skincare said it recently launched its Goat Butter Lip Mask collection at Target stores nationwide, expanding retail availability of the product line.
Dionis Goat Milk Lip Masks Launch at Target Nationwide Read More
SOUTHAMPTON, PA — Quaint Oak Bancorp, Inc. (OTCQB: QNTO) said its board of directors declared a quarterly cash dividend of $0.04 per share on the company’s common stock on April …
Quaint Oak Bancorp Declares $0.04 Quarterly Dividend Read More
LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) has rescheduled its shareholder update conference call to April 23, 2026, at 4:30 p.m. ET, as it revises financing plans tied to a …
NEXGEL Reschedules Shareholder Call, Revises Celularity Financing Read More
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) reported its financial results for the year ended December 31, 2025, and outlined progress across its antiviral pipeline, alongside a private financing …
Traws Pharma Reports 2025 Results, Secures Up to $60M Financing Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced that the U.S. Food and Drug Administration has granted Fast Track designation to its drug candidate imdusiran for the treatment of …
Arbutus Drug Candidate Receives FDA Fast Track Designation Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said the U.K.’s Medicines and Healthcare products Regulatory Agency recently accepted its marketing authorization application for MOLBREEVI to treat autoimmune pulmonary alveolar proteinosis, …
Savara Says UK Regulator Accepts MOLBREEVI Application Read More